1
73
2
| Cat. No. | Product Name | ||
|---|---|---|---|
| L4020 | NO PAINS 化合物库 | 9555 compounds | |
| LF1000 | 预制多样性库 | ||
| L9200 | 药物功能重定位化合物库 | 4240 compounds | |
| A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L7840 | 高溶解性卤化片段化合物库 | 796 compounds | |
| The highly soluble halogenated fragment library contains 796 halogenated fragment compounds. | |||
| L1000 | 上市药物库 | 2863 compounds | |
| A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L2700 | 肾上腺素能受体化合物库 | 219 compounds | |
| A unique collection of 219 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification; | |||
| L1010 | FDA上市及药典收录分子库 | 3158 compounds | |
| 3158个上市及药典分子集合，可用于高通量筛选和高内涵筛选； | |||
| L2610 | 神经递质受体化合物库 | 1513 compounds | |
| A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening； | |||
| L6010 | 天然产物库 | 3720 compounds | |
| A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
| L5500 | 毒性化合物库 | 277 compounds | |
| A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
| L3900 | DNA 损伤和修复分子库 | 937 compounds | |
| A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L2190 | 抗肺癌化合物库 | 1735 compounds | |
| A unique collection of 1735 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study； | |||
| L3980 | DNA损伤/修复库Plus | 667 compounds | |
| Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
| L4400 | 抗生素库 | 708 compounds | |
| A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening; | |||
| L9840 | 抗阿尔茨海默症化合物库 | 1040 compounds | |
| A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
| L2000 | 抑制剂库 | 7618 compounds | |
| A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L1700 | 抗病毒库 | 800 compounds | |
| A unique collection of 800 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | |||
| L8110 | 细胞重编程化合物库 | 1840 compounds | |
| A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
| L6020 | 天然产物单体化合物库 | ||
| L2400 | 内分泌激素分子库 | 813 compounds | |
| A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
| 369 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library | |||
| L1300 | PI3K/Akt/mTOR 化合物库 | 425 compounds | |
| A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | |||
| L7820 | 高溶解性微型片段化合物库 | 1082 compounds | |
| The compound library of highly soluble micro-fragments consists of 1082 low-molecular-weight fragments. | |||
| L1200 | 表观遗传库 | 960 compounds | |
| Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L4520 | 抗菌活性库 | 921 compounds | |
| A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
| L6620 | 抗寄生虫天然产物库 | 233 compounds | |
| A unique collection of 233 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
| L1800 | 抗感染化合物库 | 2977 compounds | |
| A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
| L9600 | 多肽分子库 | 533 compounds | |
| 533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
| L8700 | 铁死亡化合物库 | 800 compounds | |
| A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study； | |||
| L4700 | 免疫/炎症分子化合物库 | 3483 compounds | |
| A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening. | |||
| L4600 | 植物来源化合物库 | 3076 compounds | |
| A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
| L4510 | 抗寄生虫库 | 336 compounds | |
| 336 well-chosen unique anti-parasitic small molecules; | |||
| L6000 | 高通量筛选天然产物库 | 4320 compounds | |
| A unique collection of 4320 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen | |||
| L2600 | 神经信号分子库 | 2011 compounds | |
| A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L6810 | 中药单体化合物库 | 2688 compounds | |
| A unique collection of 2688 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism； | |||
| L2152 | 靶向治疗药物库 | 121 compounds | |
| 121 tumor-targeted drugs that can be used for high-throughput and high-content screening. | |||
| L6400 | 海洋天然产物库 | 94 compounds | |
| A unique collection of 94 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
| L2620 | 神经退行性疾病化合物库 | 1622 compounds | |
| A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS； | |||
| L9300 | 大环化合物库 | 216 compounds | |
| 216种活性已知的大环化合物，用于高通量、高内涵筛选； | |||
| L2160 | 抗癌活性化合物库 | 2439 compounds | |
| A unique collection of 2439 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L5400 | 抗心血管疾病化合物库 | 1428 compounds | |
| A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L2150 | 抗癌药物库 | 2900 compounds | |
| A unique collection of 2900 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L1900 | 抗糖尿病库 | 690 compounds | |
| A unique collection of 690 diabetes related compounds; | |||
| L2100 | 抗癌化合物库 | 6854 compounds | |
| A unique collection of 6854 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L2120 | 抗癌临床化合物库 | 2359 compounds | |
| A unique collection of 2359 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L6900 | 稀有天然产物库 | 284 compounds | |
| A unique collection of 284 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS); | |||
| L6220 | 蒙药化合物库 | 960 compounds | |
| A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
| L8800 | 药物片段库 | 1158 compounds | |
| 1158 drug fragments，a must-have tool for FBDD; | |||
| L2110 | 抗癌上市药物库 | 1806 compounds | |
| A unique collection of 1806 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L8710 | 铜死亡化合物库 | 411 compounds | |
| TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
| L6610 | 抗感染天然产物库 | 1070 compounds | |
| A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L4000 | 经典已知活性库 | 12862 compounds | |
| TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 12862 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other research. | |||
| L2180 | 抗肿瘤库Plus | 1468 compounds | |
| Well-chosen 1468 anti-tumor compounds with unique structures; | |||
| L6710 | 中药抗炎分子库 | 1260 compounds | |
| A collection of 1260 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study； | |||
| L2130 | 抗癌细胞代谢库 | 1280 compounds | |
| A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
| L8400 | 血液病分子库 | 524 compounds | |
| A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | |||
| L2191 | 抗乳腺癌化合物库 | 1965 compounds | |
| A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study； | |||
| L6200 | 瑶药化合物库 | 225 compounds | |
| A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
| L2510 | 脂代谢化合物库 | 496 compounds | |
| A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
| L5510 | 肝脏毒性化合物库 | 1040 compounds | |
| A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening； | |||
| L9500 | 表型筛选靶点鉴定库 | 1832 compounds | |
| A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening； | |||
| L5700 | 精选片段库 | 246 compounds | |
| A unique collection of 246 fragment-like small molecules for FBDD; | |||
| L5100 | 含氟化合物库 | 583 compounds | |
| A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | |||
| L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 240 compounds | |
| A unique collection of 240 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening; | |||
| L9420 | 外泌体相关化合物库 | 54 compounds | |
| 54 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
| L7100 | 抗肥胖化合物库 | 1359 compounds | |
| A unique collection of 1359 anti-obesity compounds for high throughput and high content screening; | |||
| L6800 | 中国药典收录天然产物库 | 2070 compounds | |
| A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
| L3200 | 自噬库 | 1248 compounds | |
| A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L2170 | 肿瘤免疫治疗小分子化合物库 | 454 compounds | |
| A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening； | |||
| L1500 | GPCR靶点分子库 | 1633 compounds | |
| A unique collection of 1633 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; | |||
| L4800 | 血管生成库 | 1370 compounds | |
| A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | |||
| L3300 | 组胺&褪黑色素化合物库 | 155 compounds | |
| A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L6500 | 微生物天然产物库 | 254 compounds | |
| 254种微生物来源的生物活性小分子化合物的特有集合，用于高通量、高内涵筛选； | |||
| Cat. No. | Product Name | Form | Specificity Of Inhibition |
|---|---|---|---|
| C0006 |
SYBR Green qPCR Master Mix (No ROX)
SYBR Green qPCR Master Mix (No ROX) |
||
| C0005 |
Cell Counting Kit-8 (CCK-8)
Cell Counting Kit-8 (CCK-8) |
Solution in bottle |
| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| T33632 | Neo-inositol | ||
| Neo-Inositol is a group of chemically very stable small polar molecules with a variety of properties. It is one of the naturally occurring but rare inositol stereoisomers. | |||
沪公网安备 31010602006700号
